KLK1 and pulmonary arterial hypertension: In rodent and in vitro studies, KLK1 is constitutively expressed by endothelial cells, and endothelial activation leads to release of active protease, matrix degradation, smooth muscle cell migration, and vascular sprouting [44], processes relevant to PAH.